Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000336:Aerosols; D000818:Animals; D000906:Antibodies; D000941:Antigens; D001249:Asthma / Q000209:etiology / Q000517:prevention & control; D002462:Cell Membrane / Q000187:drug effects; D002867:Chromones / Q000494:pharmacology*; D004205:Cromolyn Sodium / Q000494:pharmacology / Q000627:therapeutic use; D006632:Histamine / Q000494:pharmacology; D006636:Histamine Release; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D008407:Mast Cells / Q000166:cytology / Q000187:drug effects; D008854:Microscopy, Electron; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects; D010740:Phospholipases / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D012867:Skin / Q000201:enzymology
D000316:Adrenergic alpha-Agonists; D000336:Aerosols; D000906:Antibodies; D000941:Antigens; D002867:Chromones; D012701:Serotonin; D006632:Histamine; D010740:Phospholipases; D004205:Cromolyn Sodium